Cargando…
Pharmacological Inhibition of Glycogen Synthase Kinase 3 Regulates T Cell Development In Vitro
The development of functional T cells requires receptor-mediated transition through multiple checkpoints in the thymus. Double negative 3 (DN3) thymocytes are selected for the presence of a rearranged TCR beta chain in a process termed β-selection which requires signalling via the pre-TCR, Notch1 an...
Autores principales: | Schroeder, Jan-Hendrik, Bell, Lewis S., Janas, Michelle L., Turner, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603984/ https://www.ncbi.nlm.nih.gov/pubmed/23526989 http://dx.doi.org/10.1371/journal.pone.0058501 |
Ejemplares similares
-
Correction: Pharmacological Inhibition of Glycogen Synthase Kinase 3 Regulates T Cell Development In Vitro
por: Schroeder, Jan-Hendrik, et al.
Publicado: (2013) -
Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011) -
Inhibition of glycogen synthase kinase 3 by lithium, a mechanism in search of specificity
por: Chatterjee, Dipashree, et al.
Publicado: (2022) -
Interactomes of
Glycogen Synthase Kinase-3
Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023) -
Rosmarinic Acid Derivatives’ Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer’s Disease
por: Paudel, Pradeep, et al.
Publicado: (2018)